Status | Study |
RECRUITING |
Study Name: Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy Condition: Date: 2023-05-31 |
Not yet recruiting |
Study Name: Adrenocorticotropic Hormone in Membranous Nephropathy Condition: Membranous Nephropathy Date: 2017-01-17 Interventions: Drug: ACTHar for 6 months Other Names: |
Recruiting |
Study Name: Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy Condition: Glomerulonephritis, Membranous Date: 2017-01-09 Interventions: Drug: Rituximab Rituximab,1 g |
Not yet recruiting |
Study Name: Study on the Therapeutic Effect of TCM Treatment for MDR MN Condition: Idiopathic Membranous Nephropathy Date: 2015-11-18 Interventions: Drug: Jianpixiaozhong particles and Wuse Dietotherapy Jianpixiaozhong particles: Three packs once,bid po |
Recruiting |
Study Name: Role of Anti-mouse PLA2R1 ELISA in Membranous Nephropathy Condition: Membranous Nephropathy Date: 2014-07-22 Interventions: Procedure: Blood and urine analysis creatinine, albumin, blood electrolytes, proteinuria / creatinine in |
Recruiting |
Study Name: Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy Condition: MEMBRANOUS NEPHROPATHY Date: 2013-09-19 Interventions: Drug: TACROLIMUS Initial dose: |
Active, not recruiting |
Study Name: Clinical Study of QingReMoShen Granule to Treat Idiopathic Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2013-04-29 Interventions: Drug: Losartan Tablets & QingReMoShen Granule |
Completed |
Study Name: Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2013-01-08 Interventions: Drug: The Comprehensive Treatment Regimen of Traditional Chinese Medicine |
Withdrawn |
Study Name: Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy Condition: Glomerulonephritis, Membranous Date: 2013-01-04 Interventions: Drug: Belimumab 10 mg Belimuma |
Active, not recruiting |
Study Name: Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy Condition: Idiopathic Membranous Nephropathy Date: 2011-12-09 Interventions: Drug: symptomatic treatment (Converting Enzyme inhibitor, Angiotensin II, An |